home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9408c.zip
/
M9480597.TXT
< prev
next >
Wrap
Text File
|
1994-08-20
|
2KB
|
27 lines
Document 0597
DOCN M9480597
TI Administration of aerosol pentamidine: a program design.
DT 9410
AU O'Hara CM; Anton WR; Gormley FX; Brazell C; HIV/AIDS Programs,
University of Washington Medical Center,; Seattle.
SO J Assoc Nurses AIDS Care. 1994 Mar-Apr;5(2):41-8. Unique Identifier :
AIDSLINE MED/94305115
AB Aerosol pentamidine (AP) is an FDA-approved prophylaxis against
pneumocystis carinii pneumonia (PCP) in HIV-infected individuals who
have a CD4+ lymphocyte count less than 200/mm3, constitutional symptoms,
or a previous history of the pneumonia. The University of Washington
Medical Center, a 450-bed tertiary care center, established a successful
aerosol pentamidine treatment program, providing treatment in its
special procedure nit. The authors present an overview of AP and discuss
the role of interdisciplinary teamwork, staff training, patient
teaching, and the provision of safety measures for patients and
healthcare providers.
DE Administration, Inhalation Aerosols AIDS-Related Opportunistic
Infections/*DRUG THERAPY/NURSING Human Infection Control *Patient
Care Planning Patient Education Pentamidine/*THERAPEUTIC USE
Pneumonia, Pneumocystis carinii/*DRUG THERAPY/NURSING JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).